Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allovir Inc (ALVR)
:ALVR
Holding ALVR?
Track your performance easily
ALVR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.38 - $1.05
Previous CloseN/A
Volume83.88K
Average Volume (3M)359.05K
Market Cap
$45.44M
Enterprise Value-$28.55M
Total Cash (Recent Filing)$22.20M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.35
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.88
Shares Outstanding115,566,990
10 Day Avg. Volume428,544
30 Day Avg. Volume359,049
Standard Deviation0.23
R-Squared0.02
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.63
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AlloVir News
PremiumCompany Announcements
AlloVir Appoints Vikas Sinha as New CEO
PremiumCompany Announcements
AlloVir and Kalaris Merge to Advance Retinal Therapies
PremiumCompany Announcements
AlloVir Finalizes $7 Million Lease Termination Deal
PremiumCompany Announcements
AlloVir Ends Lease Agreement with AMAG Pharmaceuticals
PremiumCompany Announcements
AlloVir Approves Executive Bonuses for Potential 2024 Buyout
PremiumCompany Announcements
AlloVir Faces Delisting Risk, Considers Reverse Split to ComplyALVR FAQ
What was Allovir Inc’s price range in the past 12 months?
Allovir Inc lowest stock price was $0.38 and its highest was $1.05 in the past 12 months.
What is Allovir Inc’s market cap?
Allovir Inc’s market cap is $45.44M.
When is Allovir Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Allovir Inc’s earnings last quarter?
Allovir Inc released its earnings results on Aug 01, 2024. The company reported -$0.05 earnings per share for the quarter, the consensus estimate of -$0.05 by $0.
Is Allovir Inc overvalued?
According to Wall Street analysts Allovir Inc’s price is currently Overvalued.
Does Allovir Inc pay dividends?
Allovir Inc does not currently pay dividends.
What is Allovir Inc’s EPS estimate?
Allovir Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Allovir Inc have?
Allovir Inc has 115,566,990 shares outstanding.
What happened to Allovir Inc’s price movement after its last earnings report?
Allovir Inc reported an EPS of -$0.05 in its last earnings report, expectations of -$0.05. Following the earnings report the stock price went up 4.494%.
Which hedge fund is a major shareholder of Allovir Inc?
Currently, no hedge funds are holding shares in ALVR
---
AlloVir Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 2.6M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $36.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.1%
Last 30 Days ▲ 7.2%
Last 30 Days ▲ 7.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.44%
12-Months-Change
Fundamentals
Return on Equity
-63.33%
Trailing 12-Months
Asset Growth
-50.65%
Trailing 12-Months
Company Description
Allovir Inc
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.
---
ALVR Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Adaptimmune Therapeutics
―
Cellectis SA
―
Gritstone bio
―
Fate Therapeutics
―
Arcturus Therapeutics
―
Gilead Sciences
―
Best Analysts Covering ALVR
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
-36.58%
reiterated a sell rating 5 months ago
Copying Michael Ulz's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -36.58% per trade.
---